DCM
BCAX

DAFNA Capital Management’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

DAFNA Capital Management’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$2.94M Buy
317,001
+105,000
+50% +$975K 0.81% 32
2025
Q1 		$2.76M Buy
212,001
+106,501
+101% +$1.39M 0.78% 33
2024
Q4 		$1.84M Buy
+105,500
New +$1.84M 0.47% 40